US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Telix Pharmaceuticals Ltd. (Uplisting)

11.94

+0.20001.70%

Post-market: 11.80-0.1357-1.14%19:44 EDT

Volume:142.01K

Turnover:1.69M

Market Cap:4.05B

PE:125.18

High:11.95

Open:11.84

Low:11.84

Close:11.74

52wk High:12.48

52wk Low:6.28

Shares:339.00M

Float Shares:272.00M

Volume Ratio:0.92

T/O Rate:0.05%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.0954

EPS(LYR):-0.0211

ROE:7.36%

ROA:2.71%

PB:8.30

PE(LYR):-565.88

Loading ...

Overview Company News Filings

3 ASX Growth Companies With Up To 34% Insider Ownership

Simply Wall St.

Fast Growing Australian Stocks With High Insider Ownership Worth A Closer Look

Simply Wall St.

Telix Pharmaceuticals Securing FDA Nod in Line With Expectations, Says Jefferies, Shares Down 3%

MT Newswires Live

Citi Group Entities Exit Substantial Holder Status in Telix Pharmaceuticals

Telix Pharmaceuticals (ASX:TLX) Clears FDA Trial Step, Does It Look Fairly Valued?

Simply Wall St.

Telix Pharmaceuticals Gets US FDA Nod to Advance Phase 3 Prostate Cancer Trial

MT Newswires Live

3 Australian Growth Stocks With High Insider Ownership Worth Watching

Simply Wall St.

Is Telix (ASX:TLX) Using Vertical Integration To Quietly Redefine Its Radiopharmaceutical Moat?

Simply Wall St.

Telix Pharmaceuticals Stock Leads 3 Australian Growth Picks With High Insider Ownership

Simply Wall St.

Fast Growing Australian Stocks With High Insider Ownership Worth A Closer Look

Simply Wall St.

Telix Pharmaceuticals Stock And Two Australian Insider Led Growth Plays

Simply Wall St.

3 ASX Growth Stocks With Insider Backing That Deserve A Closer Look

Simply Wall St.

3 Australian Growth Stocks With High Insider Ownership And Funding Risk

Simply Wall St.

Citigroup Entities Exit Substantial Holder Status in Telix Pharmaceuticals

Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions

3 Australian Resource Stocks With High Insider Ownership And Growth Risk

Simply Wall St.

Is Telix (ASX:TLX) Using Theranostic Alliances To Deepen Its Neuro-Oncology Moat?

Simply Wall St.

3 Australian Growth Stocks With High Insider Ownership

Simply Wall St.

Fast Growing Stocks With High Insider Ownership Backing Big Growth Bets

Simply Wall St.

Telix Director David Gill Increases Stake With Nasdaq ADS Purchase

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/TLX/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TLX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TLX\",,,,,undefined,":{"symbol":"TLX","market":"US","secType":"STK","nameCN":"Telix Pharmaceuticals Ltd. (Uplisting)","latestPrice":11.94,"timestamp":1788552000000,"preClose":11.74,"halted":0,"volume":142006,"hourTrading":{"tag":"盘后","latestPrice":11.8043,"preClose":11.94,"latestTime":"19:44 EDT","volume":1130,"amount":13354.66,"timestamp":1788565476964,"change":-0.1357,"changeRate":-0.011365,"amplitude":0.011365},"delay":0,"changeRate":0.017035775127768254,"floatShares":272000000,"shares":339000000,"eps":0.095386,"marketStatus":"Market Closed","change":0.2,"latestTime":"09-04 16:00:00 EDT","open":11.84,"high":11.95,"low":11.84,"amount":1691545.792746,"amplitude":0.00937,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.095386,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788854400000},"marketStatusCode":7,"adr":0,"adrRate":1,"listingDate":1718337600000,"exchange":"NASDAQ","adjPreClose":11.74,"preHourTrading":{"tag":"盘前","latestPrice":11.82,"preClose":11.74,"latestTime":"09:29 EDT","volume":2785,"amount":33005.2257725,"timestamp":1788528599999,"change":0.08,"changeRate":0.006814,"amplitude":0.011925},"postHourTrading":{"tag":"盘后","latestPrice":11.8043,"preClose":11.94,"latestTime":"19:44 EDT","volume":1130,"amount":13354.66,"timestamp":1788565476964,"change":-0.1357,"changeRate":-0.011365,"amplitude":0.011365},"volumeRatio":0.9151416035743501},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TLX\",,,,,undefined,":{"symbol":"TLX","floatShares":272000000,"roa":"2.71%","roe":"7.36%","lyrEps":-0.0211,"volumeRatio":0.9151416035743501,"shares":339000000,"dividePrice":0,"high":11.95,"amplitude":0.00937,"preClose":11.74,"low":11.84,"week52Low":6.28,"pbRate":"8.30","psRate":"4.54","week52High":12.48,"institutionHeld":0,"latestPrice":11.94,"eps":0.095386,"divideRate":0,"volume":142006,"delay":0,"ttmEps":0.095386,"open":11.84,"prevYearClose":7.49,"prevWeekClose":11.29,"prevMonthClose":11.09,"prevQuarterClose":11.53,"fiveDayClose":11.29,"twentyDayClose":11.52,"sixtyDayClose":9.44},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TLX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-19","symbol":"TLX","fiscalQuarterEnding":"2025/12","expectedEps":0.04,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1771477200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-08-20","symbol":"TLX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755662400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-02-20","symbol":"TLX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1740027600000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TLX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TLX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6,"buy":0.4,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6,"analysts":5,"updateTime":1758254400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TLX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TLX","date":"2026-09-04","current":125.175602,"percent":0.314856,"low":-584.49693,"twenty":-444.416873,"median":171.125205,"eighty":244.246526,"high":383.853933,"avg":24.037263,"sd":311.497027,"marketCap":4026946335.18},"quantilePoints":[{"date":"2024-11-15","current":155.824924,"twenty":155.852142,"median":155.89297,"eighty":156.178762,"marketCap":4970652360.72},{"date":"2024-11-22","current":153.647458,"twenty":154.191824,"median":155.858947,"eighty":156.314854,"marketCap":4920980791.17},{"date":"2024-11-29","current":168.345354,"twenty":154.8995,"median":156.063085,"eighty":158.49232,"marketCap":5381208976.41},{"date":"2024-12-06","current":169.502133,"twenty":155.171684,"median":156.641474,"eighty":168.045953,"marketCap":5368295184.8},{"date":"2024-12-13","current":166.916392,"twenty":155.838533,"median":162.3233,"eighty":168.045953,"marketCap":5240175366.69},{"date":"2024-12-20","current":168.345354,"twenty":155.961016,"median":166.508117,"eighty":168.916939,"marketCap":5183140063.85},{"date":"2024-12-27","current":169.774316,"twenty":156.233199,"median":167.052484,"eighty":169.706271,"marketCap":5196235069.7},{"date":"2025-01-03","current":162.241165,"twenty":156.342072,"median":167.052484,"eighty":169.542961,"marketCap":4949346723.31},{"date":"2025-01-10","current":163.261978,"twenty":156.5326,"median":167.392713,"eighty":169.228803,"marketCap":4970930045.19},{"date":"2025-01-17","current":180.956065,"twenty":158.029608,"median":167.50507,"eighty":169.864326,"marketCap":5535715919.89},{"date":"2025-01-24","current":187.353158,"twenty":159.608271,"median":167.889662,"eighty":170.577257,"marketCap":5785750657.37},{"date":"2025-01-31","current":199.670965,"twenty":161.249345,"median":168.229933,"eighty":175.407845,"marketCap":6122321793.53},{"date":"2025-02-07","current":198.349538,"twenty":162.241165,"median":168.549491,"eighty":182.861582,"marketCap":6131109878.71},{"date":"2025-02-14","current":185.473256,"twenty":162.64949,"median":169.046583,"eighty":187.353158,"marketCap":5747906307.1},{"date":"2025-02-21","current":203.261161,"twenty":163.302811,"median":169.706271,"eighty":187.353158,"marketCap":6486347833.54},{"date":"2025-02-28","current":187.883767,"twenty":163.584606,"median":170.12499,"eighty":192.087093,"marketCap":5864055113.17},{"date":"2025-03-07","current":182.602424,"twenty":164.112905,"median":170.795004,"eighty":190.960114,"marketCap":5800401146.04},{"date":"2025-03-14","current":179.829719,"twenty":164.766144,"median":174.911776,"eighty":189.692293,"marketCap":5647282174.13},{"date":"2025-03-21","current":184.714961,"twenty":166.589772,"median":175.670662,"eighty":188.147066,"marketCap":5803981960.09},{"date":"2025-03-28","current":187.327482,"twenty":166.94361,"median":178.971501,"eighty":190.960114,"marketCap":5900183330.18},{"date":"2025-04-04","current":159.860903,"twenty":166.94361,"median":178.262158,"eighty":189.692293,"marketCap":5073492527.81},{"date":"2025-04-11","current":177.179731,"twenty":166.589772,"median":177.679515,"eighty":188.147066,"marketCap":5496976372.28},{"date":"2025-04-17","current":173.797147,"twenty":166.916392,"median":177.619467,"eighty":187.883767,"marketCap":5535140863.85},{"date":"2025-04-25","current":193.309359,"twenty":167.052484,"median":178.059203,"eighty":190.062144,"marketCap":6172717887.8},{"date":"2025-05-02","current":198.453445,"twenty":167.392713,"median":178.295984,"eighty":190.062144,"marketCap":6327668326.52},{"date":"2025-05-09","current":181.396737,"twenty":167.481337,"median":179.235568,"eighty":190.062144,"marketCap":5809793224.05},{"date":"2025-05-16","current":176.029393,"twenty":167.481337,"median":178.295984,"eighty":189.78972,"marketCap":5619140101.04},{"date":"2025-05-23","current":172.647682,"twenty":167.528804,"median":178.059203,"eighty":189.451294,"marketCap":5528513460.13},{"date":"2025-05-30","current":176.779306,"twenty":167.780801,"median":177.456621,"eighty":188.460572,"marketCap":5687082652.57},{"date":"2025-06-06","current":173.121803,"twenty":167.88049,"median":177.318176,"eighty":187.949592,"marketCap":5638091901.1},{"date":"2025-06-13","current":167.838743,"twenty":167.88049,"median":176.508379,"eighty":187.45928,"marketCap":5463186103.94},{"date":"2025-06-20","current":168.923551,"twenty":167.889662,"median":176.029393,"eighty":187.353158,"marketCap":5442074695.06},{"date":"2025-06-27","current":165.669807,"twenty":167.592888,"median":175.625224,"eighty":187.337752,"marketCap":5412704421.76},{"date":"2025-07-03","current":162.348276,"twenty":167.428163,"median":175.082406,"eighty":187.024133,"marketCap":5325445922.59},{"date":"2025-07-11","current":163.297285,"twenty":166.671427,"median":174.480785,"eighty":186.439488,"marketCap":5350247552.51},{"date":"2025-07-18","current":171.228286,"twenty":165.90028,"median":173.909122,"eighty":186.045921,"marketCap":5541358073.91},{"date":"2025-07-25","current":144.045965,"twenty":165.670181,"median":173.731386,"eighty":185.637634,"marketCap":4750367012.62},{"date":"2025-08-01","current":136.589468,"twenty":164.955304,"median":173.25664,"eighty":185.381192,"marketCap":4384547406.6},{"date":"2025-08-08","current":119.575098,"twenty":163.364827,"median":173.121803,"eighty":185.031841,"marketCap":3879545892.37},{"date":"2025-08-15","current":118.626089,"twenty":162.985468,"median":172.816584,"eighty":184.520886,"marketCap":3844757658.1},{"date":"2025-08-22","current":367.342977,"twenty":162.565192,"median":172.783145,"eighty":185.031841,"marketCap":3983594342.69},{"date":"2025-08-29","current":297.28853,"twenty":162.917681,"median":173.086118,"eighty":186.439488,"marketCap":3223899680.91},{"date":"2025-09-05","current":280.194275,"twenty":162.97191,"median":173.155042,"eighty":187.353158,"marketCap":3038523660.62},{"date":"2025-09-12","current":284.24913,"twenty":163.053254,"median":173.392729,"eighty":189.722035,"marketCap":3082495919.22},{"date":"2025-09-19","current":299.993591,"twenty":163.181765,"median":173.840405,"eighty":192.411646,"marketCap":3253234303.96},{"date":"2025-09-26","current":303.368871,"twenty":163.269039,"median":174.34097,"eighty":195.332201,"marketCap":3289837005.56},{"date":"2025-10-03","current":316.222238,"twenty":163.331056,"median":174.844246,"eighty":197.182743,"marketCap":3429223360.77},{"date":"2025-10-10","current":308.943311,"twenty":163.584606,"median":175.579785,"eighty":198.432664,"marketCap":3350288154.24},{"date":"2025-10-17","current":337.724829,"twenty":164.112905,"median":175.99796,"eighty":200.117317,"marketCap":3662404902.51},{"date":"2025-10-24","current":335.676999,"twenty":164.422238,"median":176.508379,"eighty":204.373856,"marketCap":3640197520.67},{"date":"2025-10-31","current":328.898919,"twenty":164.871944,"median":177.318176,"eighty":280.077091,"marketCap":3566693671.28},{"date":"2025-11-07","current":302.845362,"twenty":165.230483,"median":178.059203,"eighty":285.744085,"marketCap":3284159889.46},{"date":"2025-11-14","current":289.051675,"twenty":165.371547,"median":178.295984,"eighty":290.299055,"marketCap":3134576370.19},{"date":"2025-11-21","current":278.19044,"twenty":165.561349,"median":179.014446,"eighty":289.541689,"marketCap":3016793389.39},{"date":"2025-11-28","current":310.533522,"twenty":165.669807,"median":179.412236,"eighty":291.060611,"marketCap":3367532955.32},{"date":"2025-12-05","current":306.208941,"twenty":165.670741,"median":180.00406,"eighty":294.691227,"marketCap":3320635708.33},{"date":"2025-12-12","current":286.055209,"twenty":165.873166,"median":180.584513,"eighty":295.905706,"marketCap":3102081667.78},{"date":"2025-12-19","current":244.707348,"twenty":165.940952,"median":181.091444,"eighty":294.691227,"marketCap":2653691145.03},{"date":"2025-12-26","current":248.848958,"twenty":166.394684,"median":181.60348,"eighty":294.390689,"marketCap":2698604201.29},{"date":"2026-01-02","current":236.757004,"twenty":166.574536,"median":182.507221,"eighty":293.840477,"marketCap":2567474872.89},{"date":"2026-01-09","current":234.880062,"twenty":166.797362,"median":182.734458,"eighty":292.111558,"marketCap":2547120662.92},{"date":"2026-01-16","current":240.619616,"twenty":166.998047,"median":183.212494,"eighty":291.104403,"marketCap":2609362374.53},{"date":"2026-01-23","current":233.793317,"twenty":167.188576,"median":183.578507,"eighty":290.823686,"marketCap":2535335622.99},{"date":"2026-01-30","current":230.611959,"twenty":167.428163,"median":183.988776,"eighty":290.419247,"marketCap":2500835870.83},{"date":"2026-02-06","current":214.320895,"twenty":167.500324,"median":184.979028,"eighty":290.056234,"marketCap":2324169939.4},{"date":"2026-02-13","current":194.105832,"twenty":167.571527,"median":185.74722,"eighty":289.461299,"marketCap":2104950801.53},{"date":"2026-02-20","current":-349.931165,"twenty":167.550165,"median":186.245055,"eighty":289.186438,"marketCap":2493259551.93},{"date":"2026-02-27","current":-337.576812,"twenty":166.94361,"median":185.358176,"eighty":288.884688,"marketCap":2405234781.68},{"date":"2026-03-06","current":-357.014534,"twenty":165.886723,"median":184.229774,"eighty":287.796958,"marketCap":2543728559.75},{"date":"2026-03-13","current":-380.87359,"twenty":165.371547,"median":183.661424,"eighty":286.105301,"marketCap":2713724328.68},{"date":"2026-03-20","current":-427.441295,"twenty":164.112905,"median":183.427298,"eighty":285.888656,"marketCap":3045519229.47},{"date":"2026-03-27","current":-448.04178,"twenty":163.181765,"median":182.800475,"eighty":285.212188,"marketCap":3192297684.03},{"date":"2026-04-02","current":-425.435204,"twenty":162.890567,"median":182.629922,"eighty":285.17117,"marketCap":3031225831.43},{"date":"2026-04-10","current":-492.382264,"twenty":161.467054,"median":181.810223,"eighty":284.24913,"marketCap":3508223631.57},{"date":"2026-04-17","current":-499.465833,"twenty":158.955031,"median":181.091444,"eighty":284.07528,"marketCap":3558694058.36},{"date":"2026-04-24","current":-507.89561,"twenty":156.233199,"median":180.584513,"eighty":282.031139,"marketCap":3618756217.23},{"date":"2026-05-01","current":-532.518745,"twenty":154.872282,"median":180.00406,"eighty":281.147736,"marketCap":3794196059.21},{"date":"2026-05-08","current":-508.824558,"twenty":144.045965,"median":179.412236,"eighty":280.966174,"marketCap":3625374971.37},{"date":"2026-05-15","current":-506.065728,"twenty":140.182144,"median":178.86094,"eighty":280.209239,"marketCap":3605718311.9},{"date":"2026-05-22","current":-452.537308,"twenty":125.947014,"median":178.262158,"eighty":280.194275,"marketCap":3224328322.29},{"date":"2026-05-29","current":-444.681415,"twenty":120.122064,"median":178.059203,"eighty":279.725537,"marketCap":3168355079.47},{"date":"2026-06-05","current":-452.683664,"twenty":115.968865,"median":177.318176,"eighty":279.589795,"marketCap":3225371110.32},{"date":"2026-06-12","current":-453.131496,"twenty":29.784924,"median":176.508379,"eighty":278.469383,"marketCap":3228561906.13},{"date":"2026-06-18","current":-479.232706,"twenty":-319.885885,"median":176.029393,"eighty":275.361846,"marketCap":3414533028.17},{"date":"2026-06-26","current":-505.22407,"twenty":-336.088027,"median":175.625224,"eighty":265.637187,"marketCap":3599721496.58},{"date":"2026-07-02","current":-567.292731,"twenty":-347.690038,"median":175.082406,"eighty":259.576863,"marketCap":4041960704.33},{"date":"2026-07-10","current":-538.02731,"twenty":-371.335373,"median":174.480785,"eighty":256.751103,"marketCap":3833444584.84},{"date":"2026-07-17","current":-497.824928,"twenty":-406.861587,"median":173.909122,"eighty":252.484997,"marketCap":3547002606.6},{"date":"2026-07-24","current":-487.362208,"twenty":-419.925535,"median":173.731386,"eighty":249.449835,"marketCap":3472455733.71},{"date":"2026-07-31","current":-475.018244,"twenty":-425.317007,"median":173.324997,"eighty":249.116107,"marketCap":3384504988.78},{"date":"2026-08-07","current":-543.110083,"twenty":-431.380818,"median":173.121803,"eighty":248.587668,"marketCap":3869659340.88},{"date":"2026-08-14","current":-563.285348,"twenty":-444.416873,"median":172.850024,"eighty":247.242146,"marketCap":4013408103.64},{"date":"2026-08-21","current":112.812357,"twenty":-445.662886,"median":172.57995,"eighty":245.774025,"marketCap":3778875522.96},{"date":"2026-08-28","current":114.191675,"twenty":-444.681415,"median":171.69944,"eighty":244.665977,"marketCap":3825078550.57},{"date":"2026-09-04","current":120.218119,"twenty":-444.416873,"median":171.125205,"eighty":244.246526,"marketCap":4026946335.18}],"updateTime":1788629057113},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TLX\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2649619107","title":"3 ASX Growth Companies With Up To 34% Insider Ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2649619107","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649619107?lang=en_us&edition=fundamental","pubTime":"2026-07-06 03:08","pubTimestamp":1783278496,"startTime":"0","endTime":"0","summary":"As the Australian market opens the new financial year on a flat note, global influences such as geopolitical tensions and tech sector enthusiasm continue to shape investor sentiment. In this landscape, growth companies with high insider ownership can be particularly appealing, as they often signal strong internal confidence and alignment with shareholder interests.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/3-asx-growth-companies-with-up-to-34-insider-ownership","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/3-asx-growth-companies-with-up-to-34-insider-ownership","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BEAR.AU","AR1.AU","TLX","BK7137","QFN.AU","QRE.AU","TOR.AU","XKO.AU","BK4139","BK7110","VAS.AU","E200.AU","BK7096","AV1.AU","OZF.AU","BBOZ.AU","BK7095","MAF.AU","IISV.AU","VAP.AU","ELS.AU","IIGF.AU","OZR.AU","STW.AU","BK7023","GEAR.AU","BK7104","XJO.AU","IOZ.AU","BK7017","IMLC.AU","BK7016","EMR.AU","FRS.AU","SPL.AU","SKS.AU","SLF.AU","GIVE.AU","XAO.AU","BK7501","AEM.AU","BK7508","GYG.AU","DACE.AU","EIGA.AU","TLX.AU","ZYAU.AU","BK7084","BK7067","PNI.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649659690","title":"Fast Growing Australian Stocks With High Insider Ownership Worth A Closer Look","url":"https://stock-news.laohu8.com/highlight/detail?id=2649659690","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649659690?lang=en_us&edition=fundamental","pubTime":"2026-07-05 08:29","pubTimestamp":1783211365,"startTime":"0","endTime":"0","summary":"With inflation trends easing in some regions, interest rate paths looking more measured, and growth signals mixed across major economies, many investors are looking for companies that can rely on their own earnings power rather than broad market momentum. Fast growing stocks with high insider ownership can fit that brief, because management teams have a meaningful stake in the outcome and analysts are optimistic about their prospects. This article profiles 3 stocks from the Fast Growing...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/fast-growing-australian-stocks-with-high-insider-ownership-w-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/fast-growing-australian-stocks-with-high-insider-ownership-w-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GIVE.AU","BEAR.AU","GEAR.AU","TLX.AU","GLF.AU","OZF.AU","XKO.AU","BK4139","VAP.AU","TLX","XAO.AU","VAS.AU","IOZ.AU","ZYAU.AU","OZR.AU","BK7145","XJO.AU","BBOZ.AU","SLF.AU","STW.AU","QRE.AU","QFN.AU","LIN.AU","DACE.AU","IISV.AU","IIGF.AU","IMLC.AU","BK7067","BK7095","EIGA.AU","E200.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648565514","title":"Telix Pharmaceuticals Securing FDA Nod in Line With Expectations, Says Jefferies, Shares Down 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648565514","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648565514?lang=en_us&edition=fundamental","pubTime":"2026-07-03 14:06","pubTimestamp":1783058769,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals (ASX:TLX) reaching alignment with the US Food and Drug Administration (FDA) to advance a phase 3 trial of its TLX591-Tx therapeutic candidate is in line with expectations, accord","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TLX.AU","BK7067","TLX","LABU","BK4588","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648658492","title":"Citi Group Entities Exit Substantial Holder Status in Telix Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2648658492","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648658492?lang=en_us&edition=fundamental","pubTime":"2026-07-03 11:48","pubTimestamp":1783050524,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals ( ($AU:TLX) ) has provided an announcement. Citigroup Global Markets Australia and related Citi group entities have notified ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/citi-group-entities-exit-substantial-holder-status-in-telix-pharmaceuticals-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/citi-group-entities-exit-substantial-holder-status-in-telix-pharmaceuticals-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU2456880835.USD","LU0072461881.USD","LU0477156953.USD","BK4504","LU0648001328.SGD","LU0128525689.USD","BK4585","LU1244550577.SGD","LU0203347892.USD","LU2417539215.USD","LU2462157665.USD","BK4559","LU1244550221.USD","BK4588","LU0170899867.USD","LU0314106906.USD","LU1366192091.USD","LU0098860793.USD","LU0052756011.USD","TLX","LU0106831901.USD","IE00BSNM7G36.USD","LU1668664300.SGD","LU1201861249.SGD","LU2125154935.USD","LU2236285917.USD","LU0130517989.USD","LU2360032135.SGD","LU2125154778.USD","LU1791807156.HKD","LU0130102774.USD","LU1244550494.USD","BK4207","BK4566","LU1267930227.SGD","BK4534","LU1162221912.USD","LU0320765646.SGD","LU1506573853.SGD","LU0310800965.SGD","LU0203345920.USD","LU0980610538.SGD","LU0162691827.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648410658","title":"Telix Pharmaceuticals (ASX:TLX) Clears FDA Trial Step, Does It Look Fairly Valued?","url":"https://stock-news.laohu8.com/highlight/detail?id=2648410658","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648410658?lang=en_us&edition=fundamental","pubTime":"2026-07-03 09:41","pubTimestamp":1783042878,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals (ASX:TLX) is back in focus after a Type B meeting with the U.S. Food and Drug Administration confirmed that safety data from its ProstACT Global Phase 3 trial supports moving TLX591-Tx into Part 2.\nSee our latest analysis for Telix Pharmaceuticals.\nAlongside the FDA update, Telix Pharmaceuticals has drawn fresh attention after a strong 30-day share price return of 36.03% and year to date share price return of 51.23%. However, the 1-year total shareholder return declined...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/telix-pharmaceuticals-asxtlx-clears-fda-trial-step-does-it-l","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/telix-pharmaceuticals-asxtlx-clears-fda-trial-step-does-it-l","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","BK7067","TLX.AU","LABU","TLX","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648795527","title":"Telix Pharmaceuticals Gets US FDA Nod to Advance Phase 3 Prostate Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2648795527","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648795527?lang=en_us&edition=fundamental","pubTime":"2026-07-02 08:37","pubTimestamp":1782952632,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals  reached alignment with the US Food and Drug Administration  to advance a phase 3 trial of its TLX591-Tx therapeutic candidate in metastatic castration-resistant prostate cancer, the company said Thursday.In a type B meeting, the US regulator confirmed that safety data from part one of the study is adequate to allow for progression of part two, the company said.The launch of part two in the US remains subject to the FDA's review of an investigational new drug amendment, per the statement.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TLX","BK4588","BK4585","TLX.AU","BK7067","LABU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648252272","title":"3 Australian Growth Stocks With High Insider Ownership Worth Watching","url":"https://stock-news.laohu8.com/highlight/detail?id=2648252272","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648252272?lang=en_us&edition=fundamental","pubTime":"2026-07-02 05:42","pubTimestamp":1782942141,"startTime":"0","endTime":"0","summary":"Global manufacturing, inflation and currency trends are moving in different directions across regions, so it helps to focus on companies where management has real skin in the game and growth remains a clear priority. That is exactly what the Fast Growing Stocks With High Insider Ownership screener aims to highlight, by filtering for businesses where insiders are heavily invested alongside you and analysts see strong prospects. In this article, you will see 3 stocks from that screener that...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/3-australian-growth-stocks-with-high-insider-ownership-worth","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/3-australian-growth-stocks-with-high-insider-ownership-worth","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BBOZ.AU","IIGF.AU","OZF.AU","TLX.AU","BK7067","ZYAU.AU","IMLC.AU","XAO.AU","EIGA.AU","STW.AU","XKO.AU","BK4139","GEAR.AU","TLX","QRE.AU","LIN.AU","VAP.AU","OZR.AU","BK7145","BEAR.AU","IISV.AU","VAS.AU","E200.AU","QFN.AU","BK7095","IOZ.AU","XJO.AU","SLF.AU","GLF.AU","GIVE.AU","DACE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648481365","title":"Is Telix (ASX:TLX) Using Vertical Integration To Quietly Redefine Its Radiopharmaceutical Moat?","url":"https://stock-news.laohu8.com/highlight/detail?id=2648481365","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648481365?lang=en_us&edition=fundamental","pubTime":"2026-07-01 19:33","pubTimestamp":1782905584,"startTime":"0","endTime":"0","summary":"In late June 2026, Telix Pharmaceuticals held a special call highlighting continued commercial traction for its radiopharmaceutical portfolio, growing international reach, and ongoing clinical and partnership progress in precision oncology.\nAn interesting takeaway is the use of vertical integration and deal-making across manufacturing and distribution to strengthen Telix’s position as a global radiopharmaceutical competitor.\nWe’ll now explore how this emphasis on vertical integration and...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/is-telix-asxtlx-using-vertical-integration-to-quietly-redefi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/is-telix-asxtlx-using-vertical-integration-to-quietly-redefi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TLX","BK7067","TLX.AU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647336035","title":"Telix Pharmaceuticals Stock Leads 3 Australian Growth Picks With High Insider Ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2647336035","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647336035?lang=en_us&edition=fundamental","pubTime":"2026-06-30 12:30","pubTimestamp":1782793810,"startTime":"0","endTime":"0","summary":"With central banks rethinking interest rate paths, inflation signals mixed across regions, and consumer and trade data sending uneven messages, many investors are looking for growth stories that are grounded in management commitment rather than short term momentum. Fast Growing Stocks With High Insider Ownership focuses on companies where insiders have meaningful skin in the game and where analysts and management share an optimistic outlook. That combination can appeal if you want growth...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/telix-pharmaceuticals-stock-leads-3-australian-growth-picks","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/telix-pharmaceuticals-stock-leads-3-australian-growth-picks","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["OZR.AU","BEAR.AU","STW.AU","OZF.AU","IMLC.AU","XJO.AU","ZYAU.AU","TLX.AU","GIVE.AU","QRE.AU","IISV.AU","BK4139","TLX","E200.AU","XKO.AU","BK7095","VAS.AU","IIGF.AU","BK7067","BBOZ.AU","IOZ.AU","VAP.AU","DACE.AU","QFN.AU","GEAR.AU","XAO.AU","GLF.AU","EIGA.AU","LIN.AU","BK7145","SLF.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647340699","title":"Fast Growing Australian Stocks With High Insider Ownership Worth A Closer Look","url":"https://stock-news.laohu8.com/highlight/detail?id=2647340699","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647340699?lang=en_us&edition=fundamental","pubTime":"2026-06-29 09:14","pubTimestamp":1782695674,"startTime":"0","endTime":"0","summary":"With AI investment picking up in China, bond yields easing in several markets and consumers still spending even as inflation pressures linger, many investors are looking for companies that can grow through different parts of the cycle. Fast growing stocks with high insider ownership can be especially interesting, because management has meaningful skin in the game alongside outside shareholders. The screener used here focuses on companies where analysts and management share an optimistic...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/fast-growing-australian-stocks-with-high-insider-ownership-w","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/fast-growing-australian-stocks-with-high-insider-ownership-w","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IIGF.AU","OZF.AU","IOZ.AU","STW.AU","VAP.AU","QRE.AU","BK7145","GIVE.AU","TLX","GEAR.AU","XKO.AU","TLX.AU","DACE.AU","BBOZ.AU","XAO.AU","LIN.AU","VAS.AU","BEAR.AU","SLF.AU","OZR.AU","XJO.AU","IMLC.AU","BK4139","E200.AU","IISV.AU","ZYAU.AU","EIGA.AU","GLF.AU","QFN.AU","BK7067","BK7095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646100390","title":"Telix Pharmaceuticals Stock And Two Australian Insider Led Growth Plays","url":"https://stock-news.laohu8.com/highlight/detail?id=2646100390","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646100390?lang=en_us&edition=fundamental","pubTime":"2026-06-27 22:17","pubTimestamp":1782569834,"startTime":"0","endTime":"0","summary":"With inflation indicators mixed, central banks cautious on rates, and sector performance split between stronger services and softer manufacturing, many investors are looking for individual stocks that combine clear growth stories with management teams that have real skin in the game. The Fast Growing Stocks With High Insider Ownership screener focuses on companies where growth expectations from analysts and management line up, and insiders hold meaningful stakes. That combination can help you...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/telix-pharmaceuticals-stock-and-two-australian-insider-led-g","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/telix-pharmaceuticals-stock-and-two-australian-insider-led-g","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DACE.AU","LIN.AU","VAS.AU","ZYAU.AU","BK7067","STW.AU","GIVE.AU","BK7145","VAP.AU","IOZ.AU","QFN.AU","BBOZ.AU","GEAR.AU","IMLC.AU","TLX","TLX.AU","EIGA.AU","XAO.AU","BK7095","E200.AU","SLF.AU","XKO.AU","QRE.AU","BEAR.AU","OZR.AU","BK4139","OZF.AU","IIGF.AU","IISV.AU","XJO.AU","GLF.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646924383","title":"3 ASX Growth Stocks With Insider Backing That Deserve A Closer Look","url":"https://stock-news.laohu8.com/highlight/detail?id=2646924383","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646924383?lang=en_us&edition=fundamental","pubTime":"2026-06-26 02:17","pubTimestamp":1782411432,"startTime":"0","endTime":"0","summary":"With inflation, interest rates and global growth expectations all pulling markets in different directions, many investors are looking for companies where insiders have meaningful skin in the game and analysts see room for further expansion. That is exactly what the Fast Growing Stocks With High Insider Ownership screener focuses on. It highlights businesses where management conviction and growth potential align. This combination can help you focus on stocks that are not only growing quickly,...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/2054000-choice2-main-header/1585187245570","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2054000-choice2-main-header/1585187245570"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-ipx/iperionx-shares/news/3-asx-growth-stocks-with-insider-backing-that-deserve-a-clos","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-ipx/iperionx-shares/news/3-asx-growth-stocks-with-insider-backing-that-deserve-a-clos","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TLX.AU","BK7116","BK7095","TLX","IPX.AU","BK4139","BK7067","REMX","LIN.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645857911","title":"3 Australian Growth Stocks With High Insider Ownership And Funding Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2645857911","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645857911?lang=en_us&edition=fundamental","pubTime":"2026-06-24 07:00","pubTimestamp":1782255617,"startTime":"0","endTime":"0","summary":"With growth readings around the world sending mixed signals and services sectors under pressure in many major economies, investors are paying closer attention to stocks where management and insiders are firmly aligned with shareholders. The Fast Growing Stocks With High Insider Ownership screener filters for companies that combine strong growth potential with management teams that analysts and insiders view positively. That combination can help you focus on businesses where leaders have...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/2054000-choice2-main-header/1585187245570","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2054000-choice2-main-header/1585187245570"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-ipx/iperionx-shares/news/3-australian-growth-stocks-with-high-insider-ownership-and-f","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-ipx/iperionx-shares/news/3-australian-growth-stocks-with-high-insider-ownership-and-f","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VAP.AU","XAO.AU","TLX","IOZ.AU","IIGF.AU","E200.AU","BK4139","OZF.AU","IPX.AU","QRE.AU","IISV.AU","ZYAU.AU","XJO.AU","XKO.AU","BK7067","LIN.AU","QFN.AU","DACE.AU","EIGA.AU","SLF.AU","BBOZ.AU","GEAR.AU","BEAR.AU","BK7095","IMLC.AU","STW.AU","OZR.AU","TLX.AU","VAS.AU","GIVE.AU","BK7116"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645889867","title":"Citigroup Entities Exit Substantial Holder Status in Telix Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2645889867","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645889867?lang=en_us&edition=fundamental","pubTime":"2026-06-23 15:44","pubTimestamp":1782200652,"startTime":"0","endTime":"0","summary":"The latest update is out from Telix Pharmaceuticals ( ($AU:TLX) ). Citigroup Global Markets Australia and related Citi entities have notified Telix...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/citigroup-entities-exit-substantial-holder-status-in-telix-pharmaceuticals?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/citigroup-entities-exit-substantial-holder-status-in-telix-pharmaceuticals?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0203345920.USD","BK4139","LU0098860793.USD","LU2236285917.USD","LU0162691827.USD","LU1506573853.SGD","LU0130517989.USD","LU1244550494.USD","BK4585","LU0128525689.USD","LU0648001328.SGD","BK4207","LU1201861249.SGD","BK4588","LU1791807156.HKD","LU0203347892.USD","LU0310800965.SGD","LU1244550221.USD","LU2456880835.USD","LU2125154778.USD","LU2360032135.SGD","BK4566","LU0320765646.SGD","LU0052756011.USD","LU0106831901.USD","LU1244550577.SGD","LU1267930227.SGD","LU2417539215.USD","TLX","LU0477156953.USD","LU0314106906.USD","LU1162221912.USD","LU1668664300.SGD","LU2462157665.USD","BK4559","LU0980610538.SGD","LU2125154935.USD","BK4534","IE00BSNM7G36.USD","LU0170899867.USD","BK4504","LU0130102774.USD","LU0072461881.USD","LU1366192091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645003401","title":"Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions","url":"https://stock-news.laohu8.com/highlight/detail?id=2645003401","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645003401?lang=en_us&edition=fundamental","pubTime":"2026-06-23 05:40","pubTimestamp":1782164400,"startTime":"0","endTime":"0","summary":"MELBOURNE, Australia and INDIANAPOLIS, June  23, 2026  (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces an educational webinar exploring the unmet nee","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/22/3315649/0/en/Telix-Educational-Webinar-Neuro-Oncology-Portfolio-Update-and-Physician-Perspectives-on-Future-Therapeutic-Directions.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4141","TLX","BK4543","BK4139","BK4526","ASX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645707424","title":"3 Australian Resource Stocks With High Insider Ownership And Growth Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2645707424","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645707424?lang=en_us&edition=fundamental","pubTime":"2026-06-22 23:24","pubTimestamp":1782141854,"startTime":"0","endTime":"0","summary":"With inflation signals flickering across regions, central banks cautious on rates, and consumer sentiment mixed, many investors are looking for companies that can grow through different cycles and where insiders have meaningful skin in the game. The Fast Growing Stocks With High Insider Ownership screener focuses on businesses that combine solid growth potential with management and analyst optimism, which can help align executive incentives with shareholder outcomes. In this article you will...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/2054000-choice2-main-header/1585187245570","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2054000-choice2-main-header/1585187245570"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-ipx/iperionx-shares/news/3-australian-resource-stocks-with-high-insider-ownership-and","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-ipx/iperionx-shares/news/3-australian-resource-stocks-with-high-insider-ownership-and","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VAP.AU","XAO.AU","TLX","IOZ.AU","IIGF.AU","E200.AU","BK4139","OZF.AU","IPX.AU","QRE.AU","IISV.AU","ZYAU.AU","XJO.AU","XKO.AU","BK7067","LIN.AU","QFN.AU","DACE.AU","EIGA.AU","SLF.AU","BBOZ.AU","GEAR.AU","BEAR.AU","BK7095","IMLC.AU","STW.AU","OZR.AU","TLX.AU","VAS.AU","GIVE.AU","BK7116"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645286097","title":"Is Telix (ASX:TLX) Using Theranostic Alliances To Deepen Its Neuro-Oncology Moat?","url":"https://stock-news.laohu8.com/highlight/detail?id=2645286097","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645286097?lang=en_us&edition=fundamental","pubTime":"2026-06-21 17:21","pubTimestamp":1782033690,"startTime":"0","endTime":"0","summary":"In recent days, Telix Pharmaceuticals and United Imaging Healthcare signed a memorandum of understanding for a research collaboration in the US to combine United Imaging’s advanced scanner, software and AI platforms with Telix’s molecular imaging products, initially centred on TLX101-Px for characterizing recurrent or progressive glioma under FDA review.\nThis alliance underscores Telix’s push to integrate its radiopharmaceutical pipeline with cutting-edge imaging hardware and clinical...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/is-telix-asxtlx-using-theranostic-alliances-to-deepen-its-ne","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/is-telix-asxtlx-using-theranostic-alliances-to-deepen-its-ne","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7067","BK4139","TLX.AU","TLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644064637","title":"3 Australian Growth Stocks With High Insider Ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2644064637","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644064637?lang=en_us&edition=fundamental","pubTime":"2026-06-20 07:24","pubTimestamp":1781911491,"startTime":"0","endTime":"0","summary":"With inflation pressures, higher-for-longer interest rates and energy costs all shaping market sentiment, many investors are searching for companies where management is clearly aligned with shareholders. Fast growing stocks with high insider ownership can offer that, as insiders with meaningful stakes often focus on long term value creation and disciplined growth. Our Fast Growing Stocks With High Insider Ownership screener highlights companies that combine robust growth potential with...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2054000-choice2-main-header/1585187245570","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2054000-choice2-main-header/1585187245570"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-ipx/iperionx-shares/news/3-australian-growth-stocks-with-high-insider-ownership","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-ipx/iperionx-shares/news/3-australian-growth-stocks-with-high-insider-ownership","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DACE.AU","LIN.AU","VAS.AU","ZYAU.AU","BK7067","STW.AU","GIVE.AU","BK7116","VAP.AU","IOZ.AU","QFN.AU","BBOZ.AU","GEAR.AU","IMLC.AU","TLX","TLX.AU","EIGA.AU","XAO.AU","BK7095","E200.AU","SLF.AU","XKO.AU","IPX.AU","BEAR.AU","OZR.AU","QRE.AU","BK4139","OZF.AU","IIGF.AU","IISV.AU","XJO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644707699","title":"Fast Growing Stocks With High Insider Ownership Backing Big Growth Bets","url":"https://stock-news.laohu8.com/highlight/detail?id=2644707699","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644707699?lang=en_us&edition=fundamental","pubTime":"2026-06-18 16:42","pubTimestamp":1781772120,"startTime":"0","endTime":"0","summary":"With central banks sending mixed signals, inflation shaped by energy prices and export-heavy economies pulling in different directions, many investors are looking for companies that are less about broad market trends and more about clear internal conviction. That is where fast growing stocks with high insider ownership can be appealing, as management teams that hold meaningful stakes are often closely aligned with shareholders and appear confident enough in their own outlooks to keep...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2054000-choice2-main-header/1585187245570","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2054000-choice2-main-header/1585187245570"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-ipx/iperionx-shares/news/fast-growing-stocks-with-high-insider-ownership-backing-big-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-ipx/iperionx-shares/news/fast-growing-stocks-with-high-insider-ownership-backing-big-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["REMX","TLX","IPX.AU","BK4139","TLX.AU","BK7095","BK7116","LIN.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644795288","title":"Telix Director David Gill Increases Stake With Nasdaq ADS Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2644795288","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644795288?lang=en_us&edition=fundamental","pubTime":"2026-06-17 06:59","pubTimestamp":1781650752,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals ( ($AU:TLX) ) just unveiled an update. Telix Pharmaceuticals has disclosed a change in the holdings of director David Gill, w...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-director-david-gill-increases-stake-with-nasdaq-ads-purchase?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-director-david-gill-increases-stake-with-nasdaq-ads-purchase?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","BK4139","TLX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":199,"code":"91000000","status":"200"}]}}